Patent ID: 6521230
Filing Date: 2003-02-18
Classification: A61K,A61P,C07K

Abstract:
A CD25 binding molecule which comprises at least one antigen binding site comprising at least one domain which comprises in sequence hypervariable regions CDR1, CDR2 and CDR3, said hypervariable regions alternating with framework regions,wherein said CDR1 comprises the amino acid sequence in SEQ. ID. NO: 7, said CDR2 comprises the amino acid sequence in SEQ. ID. NO: 8 and said CDR3 comprises the amino acid sequence in SEQ. ID. NO: 9; or said CDR1, CDR2 and CDR3 taken in sequence as a whole comprise an amino acid sequence which is at least 90% identical to SEQ. ID. NOs: 7, 8 and 9 taken in sequence as a whole.